Raelipskie Partnership’s Procter & Gamble PG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.61M Buy
17,813
+861
+5% +$125K 0.99% 27
2026
Q1
$2.45M Buy
16,952
+2,222
+15% +$337K 1.04% 24
2025
Q4
$2.11M Buy
14,730
+375
+3% +$55.3K 0.89% 28
2025
Q3
$2.21M Buy
14,355
+95
+0.7% +$14.8K 0.95% 26
2025
Q2
$2.27M Buy
14,260
+3,701
+35% +$604K 1.04% 23
2025
Q1
$1.8M Buy
10,559
+233
+2% +$39K 0.92% 27
2024
Q4
$1.73M Sell
10,326
-549
-5% -$93.5K 0.86% 29
2024
Q3
$1.88M Buy
10,875
+600
+6% +$102K 0.92% 26
2024
Q2
$1.69M Hold
10,275
0.9% 27
2024
Q1
$1.67M Sell
10,275
-1,504
-13% -$236K 0.95% 25
2023
Q4
$1.73M Buy
+11,779
New +$1.74M 1.05% 25

Other funds holding PG

Raelipskie Partnership's PG Position: Q2 2026 in Review

Raelipskie Partnership increased its Procter & Gamble (PG) stake by 5.1% in Q2 2026, buying an estimated $125K and bringing the position to 17,813 shares worth $2.61M. The position accounts for 0.99% of the portfolio, ranked #27.

Raelipskie Partnership first reported a position in PG in Q4 2023 and has held it in 11 quarters since. 4,032 funds tracked by Wall St. Rank hold PG as of Q2 2026.

  • Raelipskie Partnership held 17,813 shares of Procter & Gamble worth $2.61M as of Q2 2026.
  • Raelipskie Partnership bought 861 Procter & Gamble shares in Q2 2026, an estimated $125K.
  • Procter & Gamble made up 0.99% of Raelipskie Partnership's portfolio in Q2 2026, its #27 holding.
  • Raelipskie Partnership first reported a position in Procter & Gamble in Q4 2023 and has held it in 11 quarters since.
  • 4,032 funds tracked by Wall St. Rank held Procter & Gamble as of Q2 2026.

Based on Raelipskie Partnership's 13F filing for Q2 2026, filed 4 Aug 2026.